Aft Pharma Drug Patent Portfolio
Aft Pharma owns 1 orange book drug protected by 3 US patents Given below is the list of Aft Pharma's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11197830 | Pharmaceutical composition containing acetaminophen and ibuprofen | 27 Feb, 2039 | Active |
| US11534407 | Pharmaceutical compostion containing acetominophen and ibuprofen | 27 Feb, 2039 | Active |
| US10532036 | Combination composition | 22 Sep, 2025 | Expired |
Latest Legal Activities on Aft Pharma's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Aft Pharma.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 4th Yr, Small Entity | 28 May, 2025 | US11197830 |
| Payment of Maintenance Fee, 4th Yr, Small Entity | 28 Jun, 2023 | US10532036 |
| Post Issue Communication - Certificate of Correction | 06 Jun, 2023 | US11534407 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 27 Dec, 2022 | US11534407 |
|
Recordation of Patent Grant Mailed
Critical
| 27 Dec, 2022 | US11534407 |
|
Email Notification
Critical
| 08 Dec, 2022 | US11534407 |
|
Issue Notification Mailed
Critical
| 07 Dec, 2022 | US11534407 |
|
Application Is Considered Ready for Issue
Critical
| 23 Nov, 2022 | US11534407 |
| Dispatch to FDC | 23 Nov, 2022 | US11534407 |
|
Issue Fee Payment Received
Critical
| 18 Nov, 2022 | US11534407 |
| Response to Reasons for Allowance | 18 Nov, 2022 | US11534407 |
|
Issue Fee Payment Verified
Critical
| 18 Nov, 2022 | US11534407 |
| Mailing Corrected Notice of Allowability | 09 Nov, 2022 | US11534407 |
|
Email Notification
Critical
| 09 Nov, 2022 | US11534407 |
| Corrected Notice of Allowability | 03 Nov, 2022 | US11534407 |
Aft Pharma's Family Patents
Recent FDA approvals and tentative approvals for Aft Pharma
This section lists recent FDA approvals and tentative approvals for Lupin, covering innovator and generic drugs with key regulatory details and timelines.
Innovator drugs
Includes innovator drug submissions that appear in FDA approval and tentative approval disclosures.
| Drug Name | Submission class (FDA) | Submission Category | Submission Date |
|---|---|---|---|
| Scomara |
ORIG-1
ⓘ
Orig = Original submission Suppl = Supplement submission Number = submission sequence | Type 3 - New Dosage Form | 20 Jul, 2026 |
Aft Pharma Drug List
Given below is the complete list of Aft Pharma's drugs and the patents protecting them.
1. Combogesic
Combogesic is protected by 3 patents, out of which 1 has expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11197830 | Pharmaceutical composition containing acetaminophen and ibuprofen |
27 Feb, 2039
(12 years from now)
| Active |
| US11534407 | Pharmaceutical compostion containing acetominophen and ibuprofen |
27 Feb, 2039
(12 years from now)
| Active |
| US10532036 | Combination composition |
22 Sep, 2025
(10 months ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Combogesic's drug page